Metformin vs sulfonylurea use and risk of dementia in US veterans aged >=65 years with diabetes
Conclusions:
After accounting for confounding by indication, metformin was associated with a lower risk of subsequent dementia than sulfonylurea use in veterans <75 years of age. Further work is needed to identify which patients may benefit from metformin for the prevention of dementia.
Source: Neurology - Category: Neurology Authors: Orkaby, A. R., Cho, K., Cormack, J., Gagnon, D. R., Driver, J. A. Tags: Endocrine, All Cognitive Disorders/Dementia, Alzheimer's disease, Vascular dementia, All epidemiology ARTICLE Source Type: research
More News: Alzheimer's | Brain | Dementia | Diabetes | Diabetes Type 2 | Endocrinology | Epidemiology | Fortamet | Metformin | Neurology | Study